Q4 2017 EPS Estimates for Invuity, Inc. (IVTY) Reduced by Leerink Swann

Invuity, Inc. (NASDAQ:IVTY) – Investment analysts at Leerink Swann cut their Q4 2017 earnings per share (EPS) estimates for Invuity in a research note issued on Tuesday. Leerink Swann analyst R. Newitter now forecasts that the medical instruments supplier will post earnings per share of ($0.50) for the quarter, down from their prior forecast of ($0.49). Leerink Swann also issued estimates for Invuity’s Q4 2018 earnings at ($0.53) EPS, FY2018 earnings at ($1.91) EPS and FY2019 earnings at ($1.40) EPS.

A number of other equities research analysts also recently commented on the company. Piper Jaffray Companies reaffirmed a “buy” rating and set a $12.00 target price on shares of Invuity in a report on Friday. Zacks Investment Research upgraded Invuity from a “sell” rating to a “hold” rating in a research report on Wednesday, October 4th. Northland Securities reiterated a “buy” rating and set a $13.00 price target on shares of Invuity in a research report on Tuesday, September 26th. Finally, ValuEngine upgraded Invuity from a “strong sell” rating to a “sell” rating in a research report on Friday, September 1st. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $11.67.

WARNING: This article was first posted by Markets Daily and is the property of of Markets Daily. If you are viewing this article on another website, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this article can be accessed at https://www.themarketsdaily.com/2017/11/12/q4-2017-eps-estimates-for-invuity-inc-ivty-reduced-by-leerink-swann.html.

Shares of Invuity (NASDAQ IVTY) opened at $8.45 on Friday. The company has a debt-to-equity ratio of 5.39, a quick ratio of 2.63 and a current ratio of 2.90. Invuity has a twelve month low of $5.70 and a twelve month high of $9.70.

Invuity (NASDAQ:IVTY) last released its earnings results on Tuesday, November 7th. The medical instruments supplier reported ($0.52) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.56) by $0.04. Invuity had a negative return on equity of 212.38% and a negative net margin of 111.43%. The firm had revenue of $9.60 million during the quarter, compared to the consensus estimate of $9.87 million.

Institutional investors have recently bought and sold shares of the company. CAPROCK Group Inc. increased its position in shares of Invuity by 28.6% in the third quarter. CAPROCK Group Inc. now owns 45,000 shares of the medical instruments supplier’s stock valued at $401,000 after buying an additional 10,000 shares in the last quarter. OxFORD Asset Management LLP purchased a new stake in shares of Invuity in the second quarter valued at approximately $374,000. B. Riley Financial Inc. purchased a new stake in shares of Invuity during the second quarter worth approximately $3,625,000. Royce & Associates LP increased its position in shares of Invuity by 141.9% during the second quarter. Royce & Associates LP now owns 98,939 shares of the medical instruments supplier’s stock worth $717,000 after purchasing an additional 58,033 shares in the last quarter. Finally, FMR LLC increased its position in shares of Invuity by 0.5% during the first quarter. FMR LLC now owns 829,564 shares of the medical instruments supplier’s stock worth $6,595,000 after purchasing an additional 4,264 shares in the last quarter. Institutional investors and hedge funds own 66.01% of the company’s stock.

About Invuity

Invuity, Inc, a medical technology company, develops various surgical devices to address various surgical procedures in the United States. The company integrates its intelligent photonics technology platform into its single-use and reusable advanced surgical devices to address various critical intracavity illumination and visualization challenges.

Earnings History and Estimates for Invuity (NASDAQ:IVTY)

Receive News & Ratings for Invuity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invuity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply